HIGHLIGHTS
- who: Valentina Agnolon from the University of London, United Kingdom have published the research: Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity, in the Journal: (JOURNAL)
- what: Similar approaches were also applied for the production of EBOV GP trimers to be used mainly for structural biology studies aimed to investigate the formation of complexes between GP and neutralizing antibodies or other therapeutic molecules . Currently, viral_vector-based vaccines lead vaccine research against EVD and the amount of published work focusing on preclinical and clinical studies using recombinant EBOV GP Frontiers in Immunology . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.